Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

A usability study of a computerized decision aid to help patients with, early stage papillary thyroid carcinoma in, decision-making on adjuvant radioactive iodine treatment.

Sawka AM, Straus S, Gafni A, Meiyappan S, O'Brien MA, Brierley JD, Tsang RW, Rotstein L, Thabane L, Rodin G, George SR, Goldstein DP.

Patient Educ Couns. 2011 Aug;84(2):e24-7. doi: 10.1016/j.pec.2010.07.038.

PMID:
20732775
2.

Randomized controlled trial of a computerized decision aid on adjuvant radioactive iodine treatment for patients with early-stage papillary thyroid cancer.

Sawka AM, Straus S, Rotstein L, Brierley JD, Tsang RW, Asa S, Segal P, Kelly C, Zahedi A, Freeman J, Solomon P, Anderson J, Thorpe KE, Gafni A, Rodin G, Goldstein DP.

J Clin Oncol. 2012 Aug 10;30(23):2906-11. doi: 10.1200/JCO.2011.41.2734.

PMID:
22753906
3.

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer--a randomized controlled trial.

Sawka AM, Straus S, Brierley JD, Tsang RW, Rotstein L, Rodin G, Gafni A, Ezzat S, Thabane L, Thorpe KE, Goldstein DP.

Trials. 2010 Jul 26;11:81. doi: 10.1186/1745-6215-11-81.

4.

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer: update to study protocol with follow-up extension.

Sawka AM, Straus S, Rodin G, Thorpe KE, Ezzat S, Gafni A, Goldstein DP.

Trials. 2015 Jul 14;16:302. doi: 10.1186/s13063-015-0819-6.

5.
6.

How can we meet the information needs of patients with early stage papillary thyroid cancer considering radioactive iodine remnant ablation?

Sawka AM, Straus S, Gafni A, Brierley JD, Tsang RW, Rotstein L, Ezzat S, Thabane L, Rodin G, Meiyappan S, David D, Goldstein DP.

Clin Endocrinol (Oxf). 2011 Apr;74(4):419-23. doi: 10.1111/j.1365-2265.2010.03966.x.

7.

Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow-up from a decision-aid randomized trial.

Sawka AM, Straus S, Rodin G, Heus L, Brierley JD, Tsang RW, Rotstein L, Ezzat S, Segal P, Gafni A, Thorpe KE, Goldstein DP.

Cancer. 2015 Oct 15;121(20):3717-26. doi: 10.1002/cncr.29548.

8.

Basis for physician recommendations for adjuvant radioiodine therapy in early-stage thyroid carcinoma: principal findings of the Canadian-American thyroid cancer survey.

Sawka AM, Goldstein DP, Thabane L, Brierley JD, Tsang RW, Rotstein L, Kamalanathan S, Zhao B, Gafni A, Straus S, Ezzat S.

Endocr Pract. 2008 Mar;14(2):175-84.

PMID:
18308655
9.

Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group.

Hölzer S, Reiners C, Mann K, Bamberg M, Rothmund M, Dudeck J, Stewart AK, Hundahl SA.

Cancer. 2000 Jul 1;89(1):192-201.

PMID:
10897018
10.

Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy.

Chow SM, Law SC, Mendenhall WM, Au SK, Chan PT, Leung TW, Tong CC, Wong IS, Lau WH.

Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):784-95.

PMID:
11849802
11.

Thyroid cancer patients' involvement in adjuvant radioactive iodine treatment decision-making and decision regret: an exploratory study.

Sawka AM, Straus S, Gafni A, Meiyappan S, David D, Rodin G, Brierley JD, Tsang RW, Thabane L, Rotstein L, Ezzat S, Goldstein DP.

Support Care Cancer. 2012 Mar;20(3):641-5. doi: 10.1007/s00520-011-1302-x.

12.

Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.

Grigsby PW, Reddy RM, Moley JF, Hall BL.

Surgery. 2006 Dec;140(6):1043-7; discussion 1047-9.

PMID:
17188155
13.

The impact of socioeconomic status on the use of adjuvant radioactive iodine for papillary thyroid cancer.

Zevallos JP, Xu L, Yiu Y.

Thyroid. 2014 Apr;24(4):758-63. doi: 10.1089/thy.2013.0409.

PMID:
24378070
14.
15.

The impact of thyroid cancer and post-surgical radioactive iodine treatment on the lives of thyroid cancer survivors: a qualitative study.

Sawka AM, Goldstein DP, Brierley JD, Tsang RW, Rotstein L, Ezzat S, Straus S, George SR, Abbey S, Rodin G, O'Brien MA, Gafni A, Thabane L, Goguen J, Naeem A, Magalhaes L.

PLoS One. 2009;4(1):e4191. doi: 10.1371/journal.pone.0004191.

17.

Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.

Chen PV, Osborne R, Ahn E, Avitia S, Juillard G.

Ear Nose Throat J. 2009 Jul;88(7):E01.

PMID:
19623515
18.

The role of radioactive iodine in the treatment of advanced differentiated thyroid carcinoma.

Pelikan DM, Lion HL, Hermans J, Goslings BM.

Clin Endocrinol (Oxf). 1997 Dec;47(6):713-20.

PMID:
9497879
19.

Treatment for microcarcinoma of the thyroid--clinical experience.

Küçük NO, Tari P, Tokmak E, Aras G.

Clin Nucl Med. 2007 Apr;32(4):279-81.

PMID:
17413573
20.

Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.

Lin JD, Lin KJ, Chao TC, Hseuh C, Tsang NM.

Radiother Oncol. 2008 Oct;89(1):97-104. doi: 10.1016/j.radonc.2008.05.011.

PMID:
18534700
Items per page

Supplemental Content

Support Center